BiotechTube
Home/Nanexa/Anders Johansson
AJ

Anders Johansson

Head of Intellectual Property, Co-founder

Nanexa

Roles

Head of Intellectual Property, Co-founderatNanexa
Head of Intellectual Property, Co-founderatnanexa-ab

Therapeutic Areas

Metabolic DiseasesOncology

Nanexa Pipeline

DrugIndicationPhase
NEX-22Type 2 Diabetes / Obesity (Liraglutide)Phase I
NEX-20Oncology (Undisclosed)Preclinical
NEX-18Oncology (Undisclosed)Preclinical
Moderna CollaborationUndisclosedDiscovery
AstraZeneca CollaborationUndisclosedResearch
Novo Nordisk CollaborationUndisclosedResearch

Leadership Team at Nanexa

DW
David Westberg
Chief Executive Officer
CD
Cecilia Danckwardt-Lillieström
Chief Financial Officer
MR
Mårten Rooth
Chief Technology Officer, Co-founder
JH
Joel Hellrup
Head of Pharmaceutical R&D
KB
Kristine Bäck
Director Project Management
GA
Göran Ando
Chairman of the Board
BS
Birgit Stattin Norinder
Board Member
RD
Richard Davis
Board Member
JD
Jakob Dynnes Hansen
Board Member
View full Nanexa profile